Biotech Values

[ghmm]

Going through Clinical Trials.gov noticed the follow Phase 2 programs think all are on the list for those wanting more info the links and a couple things I noticed are below.

http://clinicaltrials.gov/ct2/show/NCT00797745 - Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1
. They have 6 arms + SOC. Using ritonavir, Some 4 week lead in, once and twice daily
. 140 patients

http://clinicaltrials.gov/ct2/show/NCT00561353 - OPERA 1: A Study of the Hepatitis C Virus (HCV) Protease Inhibitor TMC435350
. (25 mg daily or 75 mg daily or 200 mg daily or 400 mg daily)
. 130 patients

http://clinicaltrials.gov/ct2/show/NCT00774397 - Antiviral Effect and Safety of BI201335 +PegIFN/RBV in HCV-GT1
. 24 weeks, 700 patients